Succinctly put @FloatingCity
I also vaguely remember a comment that DMX200 might have reversed the disease for people with relatively low levels of proteinuria. But agree that DXB will have been smart if designing this trial around patients with a higher baseline of proteinuria for maximum effect.
Succinctly put @FloatingCityI also vaguely remember a comment...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.015(4.17%) |
Mkt cap ! $189.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 34.0¢ | $1.344M | 3.820M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 379330 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 120368 | 4 |
View Market Depth
| Last trade - 13.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.5¢ |
Change
-0.015 ( 4.14 %) |
||||
| Open | High | Low | Volume | ||
| 36.5¢ | 37.0¢ | 34.0¢ | 1580400 | ||
| Last updated 13.32pm 06/05/2024 ? | |||||
| DXB (ASX) Chart |